AUTHOR
Caitlin Barkume, Kashmira Date, Samir K Saha, Farah Naz Qamar, Dipika Sur, Jason R Andrews, Stephen P Luby, M Imran Khan, Alex Freeman, Mohammad Tahir Yousafzai, Denise Garrett.
ABSTRACT
OBJECTIVE:
The objective of Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP), a multiphase surveillance study characterizing the burden of disease in South Asia, was to inform data collection for prospective surveillance and to capture clinical aspects of disease.
RESULTS:
Of all blood cultures performed in Bangladesh, India, Nepal, and Pakistan, 1.5%, 0.43%, 2%, and 1.49%, respectively, were positive for S. Typhi and 0.24%, 0.1%, 0.5%, and 0.67%, respectively, were positive for S. Paratyphi. A higher proportion of laboratory-confirmed infections in Bangladesh and Pakistan were aged ≤5 years, while India and Nepal had a higher proportion of participants aged 15–25 years. In all countries, the sex of the majority of participants was male. The majority of isolates in all countries were resistant to fluoroquinolones, with a high proportion also resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.
Click here to view the article, published in The Journal of Infectious Diseases.
